2HPβCD
VAR200-0301
Phase 2 small_molecule terminated
Quick answer
2HPβCD for Diabetic Kidney Disease is a Phase 2 program (small_molecule) at ZyVersa Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ZyVersa Therapeutics
- Indication
- Diabetic Kidney Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated